Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael F. Princiotta is active.

Publication


Featured researches published by Michael F. Princiotta.


Nature | 2003

Phagosomes are competent organelles for antigen cross-presentation

Mathieu Houde; Sylvie Bertholet; Etienne Gagnon; Sylvain Brunet; Guillaume Goyette; Annie Laplante; Michael F. Princiotta; Pierre Thibault; David L. Sacks; Michel Desjardins

The ability to process microbial antigens and present them at the surface of cells is an important aspect of our innate ability to clear infections. It is generally accepted that antigens in the cytoplasm are loaded in the endoplasmic reticulum and presented at the cell surface on major histocompatibility complex (MHC) class I molecules, whereas peptides present in endo/phagocytic compartments are presented on MHC class II molecules. Despite the apparent segregation of the class I and class II pathways, antigens from intracellular pathogens including mycobacteria, Escherichia coli, Salmonella typhimurium, Brucella abortus and Leishmania, have been shown to elicit an MHC class-I-dependent CD8+ T-cell response, a process referred to as cross-presentation. The cellular mechanisms allowing the cross-presentation pathway are poorly understood. Here we show that phagosomes display the elements and properties needed to be self-sufficient for the cross-presentation of exogenous antigens, a newly ascribed function linked to phagocytosis mediated by the endoplasmic reticulum.


Immunity | 2003

Quantitating protein synthesis, degradation, and endogenous antigen processing.

Michael F. Princiotta; Diana Finzi; Shu-Bing Qian; James Gibbs; Sebastian Schuchmann; Frank Buttgereit; Jack R. Bennink; Jonathan W. Yewdell

Using L929 cells, we quantitated the macroeconomics of protein synthesis and degradation and the microeconomics of producing MHC class I associated peptides from viral translation products. To maintain a content of 2.6 x 10(9) proteins, each cells 6 x 10(6) ribosomes produce 4 x 10(6) proteins min(-1). Each of the cells 8 x 10(5) proteasomes degrades 2.5 substrates min(-1), creating one MHC class I-peptide complex for each 500-3000 viral translation products degraded. The efficiency of complex formation is similar in dendritic cells and macrophages, which play a critical role in activating T cells in vivo. Proteasomes create antigenic peptides at different efficiencies from two distinct substrate pools: rapidly degraded newly synthesized proteins that clearly represent defective ribosomal products (DRiPs) and a less rapidly degraded pool in which DRiPs may also predominate.


Journal of Immunology | 2001

Multiple Antigen-Specific Processing Pathways for Activating Naive CD8+ T Cells In Vivo

Christopher C. Norbury; Michael F. Princiotta; Igor Bacik; Randy R. Brutkiewicz; Phillip Wood; Tim Elliott; Jack R. Bennink; Jonathan W. Yewdell

Current knowledge of the processing of viral Ags into MHC class I-associated ligands is based almost completely on in vitro studies using nonprofessional APCs (pAPCs). This is two steps removed from real immune responses to pathogens and vaccines, in which pAPCs activate naive CD8+ T cells in vivo. Rational vaccine design requires answers to numerous questions surrounding the function of pAPCs in vivo, including their abilities to process and present peptides derived from endogenous and exogenous viral Ags. In the present study, we characterize the in vivo dependence of Ag presentation on the expression of TAP by testing the immunogenicity of model Ags synthesized by recombinant vaccinia viruses in TAP1−/− mice. We show that the efficiency of TAP-independent presentation in vitro correlates with TAP-independent activation of naive T cells in vivo and provide the first in vivo evidence for proteolytic processing of antigenic peptides in the secretory pathway. There was, however, a clear exception to this correlation; although the presentation of the minimal SIINFEKL determinant from chicken egg OVA in vitro was strictly TAP dependent, it was presented in a TAP-independent manner in vivo. In vivo presentation of the same peptide from a fusion protein retained its TAP dependence. These results show that determinant-specific processing pathways exist in vivo for the generation of antiviral T cell responses. We present additional findings that point to cross-priming as the likely mechanism for these protein-specific differences.


Journal of Biological Chemistry | 2006

Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control.

Shu-Bing Qian; Michael F. Princiotta; Jack R. Bennink; Jonathan W. Yewdell

Approximately 30% of polypeptides synthesized by mammalian cells are degraded with a half-life of <10 min by proteasomes. These rapidly degraded polypeptides (RDPs) constitute the bulk of proteasome substrates and are the principal source of viral and self-peptide ligands for major histocompatibility complex class I molecules. Here we provide evidence that ∼75% of RDPs are degraded by the standard ubiquitin 26 S proteasome system and that their degradation is regulated by modulating Hsc70 activity in cells. Surprisingly, the remaining ∼25% of RDPs are degraded without ubiquitylation by 20 S proteasomes independently of 19 S regulators and in a manner that is largely unaffected by modulating Hsc70 activity. This latter pathway is utilized for generating an antigenic peptide from viral-defective ribosomal products. The dichotomy in the behavior of RDPs points to a novel quality control level for nascent proteins that is independent of the well established Hsc70-ubiquitin 26 S proteasome pathway.


Proceedings of the National Academy of Sciences of the United States of America | 2010

Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action

Avital Lev; Michael F. Princiotta; Damian Zanker; Kazuyo Takeda; James Gibbs; Chiharu Kumagai; Elizabeth Waffarn; Brian P. Dolan; Anne Burgevin; Peter van Endert; Weisan Chen; Jack R. Bennink; Jonathan W. Yewdell

MHC class I molecules function to display peptides generated from cellular and pathogen gene products for immune surveillance by CD8+ T cells. Cells typically express ∼100,000 class I molecules, or ∼1 per 30,000 cellular proteins. Given “one protein, one peptide” representation, immunosurveillance would be heavily biased toward the most abundant cell proteins. Cells use several mechanisms to prevent this, including the predominant use of defective ribosomal products (DRiPs) to generate peptides from nascent proteins and, as we show here, compartmentalization of DRiP peptide generation to prevent competition from abundant cytosolic peptides. This provides an explanation for the exquisite ability of T cells to recognize peptides generated from otherwise undetected gene products.


Journal of Neuroimmunology | 2005

Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generation

M.E. Truckenmiller; Michael F. Princiotta; Christopher C. Norbury; Robert H. Bonneau

The presentation of viral peptide-MHC class I complexes by antigen presenting cells, such as dendritic cells (DCs), is obligatory for the generation of antiviral effector and memory CD8(+) cytotoxic T lymphocyte (CTL) responses. Prolonged psychological stress is immunosuppressive and undermines primary and memory CTL-mediated antiviral immunity; however, the mechanisms involved are unknown. Using a panel of novel reagents and techniques, we quantitatively measured the effect of the stress-induced hormone corticosterone (CORT) on the efficiency of DCs to process and present virally expressed antigen, characterized the conditions for this CORT-mediated effect, and delineated the components of the MHC class I pathway that were affected. We found that physiologically relevant levels of CORT, prior to infection and acting via the glucocorticoid receptor, suppressed the formation of peptide-MHC class I complexes on the surface of infected DCs. We further showed that this suppression of peptide-MHC class I complexes is via the action of CORT on elements of the class I pathway upstream from TAP that are involved in the generation of antigenic peptides. This CORT-mediated suppression of peptide-class I complexes on DCs also resulted in a marked reduction of their ability to activate a specific T cell hybridoma. These findings offer a mechanism contributing to the stress-induced suppression of host defenses against viral diseases and have implications for the efficacy of antiviral vaccines. At the most fundamental cellular level, this impairment of antigen processing has implications for the regulation of protein degradation in all cells, which is critical to many aspects of immune function.


Journal of Immunology | 2011

A Marked Reduction in Priming of Cytotoxic CD8+ T Cells Mediated by Stress-Induced Glucocorticoids Involves Multiple Deficiencies in Cross-Presentation by Dendritic Cells

John Hunzeker; Michael D. Elftman; Jennifer C. Mellinger; Michael F. Princiotta; Robert H. Bonneau; M.E. Truckenmiller; Christopher C. Norbury

Protracted psychological stress elevates circulating glucocorticoids, which can suppress CD8+ T cell-mediated immunity, but the mechanisms are incompletely understood. Dendritic cells (DCs), required for initiating CTL responses, are vulnerable to stress/corticosterone, which can contribute to diminished CTL responses. Cross-priming of CD8+ T cells by DCs is required for initiating CTL responses against many intracellular pathogens that do not infect DCs. We examined the effects of stress/corticosterone on MHC class I (MHC I) cross-presentation and priming and show that stress/corticosterone-exposed DCs have a reduced ability to cross-present OVA and activate MHC I-OVA257–264-specific T cells. Using a murine model of psychological stress and OVA-loaded β2-microglobulin knockout “donor” cells that cannot present Ag, DCs from stressed mice induced markedly less Ag-specific CTL proliferation in a glucocorticoid receptor-dependent manner, and endogenous in vivo T cell cytolytic activity generated by cross-presented Ag was greatly diminished. These deficits in cross-presentation/priming were not due to altered Ag donation, Ag uptake (phagocytosis, receptor-mediated endocytosis, or fluid-phase uptake), or costimulatory molecule expression by DCs. However, proteasome activity in corticosterone-treated DCs or splenic DCs from stressed mice was partially suppressed, which limits formation of antigenic peptide–MHC I complexes. In addition, the lymphoid tissue-resident CD11b−CD24+CD8α+ DC subset, which carries out cross-presentation/priming, was preferentially depleted in stressed mice. At the same time, CD11b−CD24+CD8α− DC precursors were increased, suggesting a block in development of CD8α+ DCs. Therefore, glucocorticoid-induced changes in both the cellular composition of the immune system and intracellular protein degradation contribute to impaired CTL priming in stressed mice.


Journal of Immunology | 2000

A Physiological Ligand of Positive Selection Is Recognized as a Weak Agonist

Rance E. Berg; Stefan Irion; Steve Kattman; Michael F. Princiotta; Uwe D. Staerz

Positive selection is a process that ensures that peripheral T cells express TCR that are self-MHC restricted. This process occurs in the thymus and requires both self-MHC and self-peptides. We have recently established a TCR transgenic (TCRtrans+) mouse model using the C10.4 TCR restricted to the MHC class Ib molecule, H2-M3. Having defined H2-M3 as the positively selecting MHC molecule, the severely limited number of H2-M3 binding peptides allowed us to characterize a mitochondrial NADH dehydrogenase subunit 1-derived 9-mer peptide as the physiological ligand of positive selection. Here, we demonstrate that the NADH dehydrogenase subunit 1 self-peptide is seen by mature C10.4 TCRtrans+ T cells as a weak agonist and induces positive selection at a defined concentration range. We also found that the full-length cognate peptide, a strong agonist for mature C10.4 TCRtrans+ T cells, initiated positive selection, albeit at significantly lower concentrations. At increased peptide concentrations, and thus increased epitope densities, either peptide only induced the development of partially functional T cells. We conclude that successful positive selection only proceeded at a defined, yet fairly narrow window of avidity.


Blood | 2012

All roads lead to “ome”: defining the DRiPome

Jonathan W. Yewdell; Michael F. Princiotta

In this issue of Blood , Granados et al explore the relationship between the cellular transcriptome and immunopeptidome,[1][1],[2][2] the repertoire of peptides presented by MHC class I molecules for immunosurveillance. Class I molecules are encoded by 3 highly polymorphic genes, HLA-A, -B, and -C


Proceedings of the National Academy of Sciences of the United States of America | 2000

Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2

Ulrich S. Schubert; David E. Ott; Elena Chertova; Reinhold Welker; Uwe Tessmer; Michael F. Princiotta; Jack R. Bennink; Hans-Georg Kräusslich; Jonathan W. Yewdell

Collaboration


Dive into the Michael F. Princiotta's collaboration.

Top Co-Authors

Avatar

Jonathan W. Yewdell

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jack R. Bennink

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Benjamin Wolf

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Robert H. Bonneau

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Igor Bacik

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keri B. Donohue

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

M.E. Truckenmiller

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Michael D. Elftman

Pennsylvania State University

View shared research outputs
Researchain Logo
Decentralizing Knowledge